文献速递外周动脉疾病内脏/肾动脉与血管畸形

髂动脉分叉覆膜支架腔内重建术(CERIB)

Covered Endovascular Reconstruction of the Iliac Artery Bifurcation (CERIB).
PubMed 文献 · J Endovasc Ther · 2024-06-16

本回顾性单中心研究纳入2021年1月至2022年12月接受CERIB术的全部13例主髂动脉闭塞性疾病累及髂动脉分叉患者,技术成功率100%,中位随访18个月期间2例死于心血管原因、1例既往髂动脉支架者因再闭塞需再干预。作者认为CERIB是保留髂内动脉灌注的直观治疗选择,早期和中期结果良好,既往髂动脉支架可能是早期闭塞的危险因素。

要点

  • CERIB术技术成功率为100%,中位随访18个月期间2例死于心血管原因。
  • 1例既往髂动脉支架患者因再闭塞需再干预,作者认为既往髂动脉支架可能是早期闭塞危险因素。
  • 作者认为CERIB可保留髂内动脉灌注,是治疗累及髂动脉分叉的主髂动脉闭塞性疾病的直观选择。

核心结论

  • 作者认为CERIB是治疗累及髂动脉分叉的主髂动脉闭塞性疾病的直观选择,可保留髂内动脉灌注,早期和中期结果良好。
  • 作者认为既往髂动脉支架可能是CERIB术后早期闭塞的危险因素。

研究设计与样本

  • 本回顾性单中心研究纳入2021年1月至2022年12月接受CERIB术的全部患者,共13例(11/13为男性,中位年龄70岁[60-76岁])。
  • CERIB术经皮双侧股动脉入路完成,因外周动脉闭塞性疾病范围需同期开放股动脉重建者除外。
  • 收集并分析标准患者、手术及随访数据,包括生存和动脉再干预。

主要发现

  • 附加开放和/或腔内手术包括股动脉分叉内膜剥脱术(n=6)、旋磨斑块切除术(n=2)和1例腋动脉切开以上肢入路(n=1)。
  • 中位手术时间2.9小时(1.5-4.9小时),中位辐射时间28.4分钟(14.3-63.3分钟),中位辐射剂量4090.6 cGray/cm2(384.4-9430.1 cGray/cm2)。
  • CERIB所用覆膜支架为BeGraft peripheral n=31、BeGraft Aortic n=4和BeGraft peripheral plus n=1(Bentley InnoMed GmbH, Hechingen, Germany)。
  • 2例既往髂总动脉支架患者本研究仅处理髂内和髂外动脉,2例需附加裸支架行内衬。
  • 技术成功率为100%;中位随访18个月(4-31个月)期间2例死于心血管原因,1例既往髂动脉支架患者因再闭塞需再干预。

临床怎么用

  • 作者认为CERIB可作为治疗累及髂动脉分叉的主髂动脉闭塞性疾病的直观选择,以保留髂内动脉灌注。
  • 作者认为既往髂动脉支架可能是CERIB术后早期闭塞的危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to present the covered endovascular reconstruction of the iliac artery bifurcation (CERIB) technique as a revascularization option for aorto-iliac occlusive disease (AIOD) involving the iliac artery bifurcation. METHODS: This was a retrospective single-center study including all patients undergoing a CERIB procedure from January 2021 until December 2022. Covered endovascular reconstruction of the iliac artery bifurcation procedures were performed percutaneously with bilateral femoral access, excepting cases where simultaneous open femoral artery reconstruction was required due to the extension of peripheral arterial occlusive disease. Standard patient, procedural, and follow-up (FU) data including survival and arterial reinterventions were gathered and analyzed. RESULTS: A total of 13 patients were included (11/13 male, median age=70 [60-76] years). Additional open and/or endovascular procedures included endarterectomy of the femoral bifurcation (n=6), rotational atherectomy (n=2), and 1 axillary artery cutdown for upper limb access (n=1). Median operating time was 2.9 hours (1.5-4.9 hours); median radiation duration and dose were 28.4 (14.3-63.3 minutes) and 4090.6 (384.4-9430.1 cGray/cm2), respectively. The stent grafts used for CERIB were BeGraft peripheral n=31, BeGraft Aortic n=4 and BeGraft peripheral plus n=1 (Bentley InnoMed GmbH, Hechingen, Germany). In 2 patients with prior stenting of the common iliac artery (CIA), only the internal and external iliac arteries (IIA and EIA) were treated in this study, and in 2 cases, additional uncovered stents were required for relining. Technical success was 100%. During a midterm FU (median 18 [4-31] months), 2 patients died from cardiovascular reasons and 1 patient with prior iliac stenting required reinterventions for recurring occlusion. CONCLUSION: Covered endovascular reconstruction of the iliac artery bifurcation is a straightforward option for treating AIOD involving the iliac artery bifurcation that allows preservation of internal iliac artery perfusion and shows good early and midterm results. Prior iliac artery stenting may be a risk factor for early occlusion after CERIB.Clinical impactAorto-iliac occlusive disease with involvement of the internal iliac artery is encountered regularly in vascular surgical practice, but the internal iliac artery is often not included in the revascularization strategy. The present article will increase the awareness for the relevance of including the internal iliac artery in revascularization strategies and presents CERIB as another method to be added to the armamentarium of (endo-)vascular surgeons and interventionalists.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Keschenau PR, Stark M, Weiss B, et al. Covered Endovascular Reconstruction of the Iliac Artery Bifurcation (CERIB). J Endovasc Ther. 2024. PMID: 38880997. doi:10.1177/15266028241258659

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。